ATROVENT HFA
ATROVENT HFA
Approved
DIN Number
02247686
Drug Class
Human
Market Date
Mar 24, 2004
Company
HC
boehringer ingelheim (canada) ltd ltee
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02247686
AIG Number0115643002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
R03BB01 IPRATROPIUM BROMIDE
Product Specifications
Dosage FormMetered-Dose Aerosol
Route of AdministrationInhalation
AHFS Classification12:08.08
Health Canada Classification
ACTIVE INGREDIENTS (1)
IPRATROPIUM BROMIDEActive
Strength: 20 MCG / ACT
Monograph: IPRATROPIUM BROMIDE